Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Egyptian Center for Research and Regenerative Medicine (ECRRM) is a premier biomedical research institution based in Cairo, Egypt, operating under the auspices of the Egyptian Ministry of Defense. The center specializes in regenerative medicine, stem cell research, and genomics, aiming to provide innovative therapeutic solutions for chronic and complex diseases. ECRRM gained significant prominence for its role in developing Covi Vax, Egypt's first indigenous COVID-19 vaccine, in collaboration with national and international partners. Its facilities include advanced laboratories for molecular biology, tissue engineering, and a dedicated clinical trials unit. The center serves as a strategic hub for the Egyptian Genome Project, focusing on personalized medicine and genetic research within the region. ECRRM collaborates extensively with national universities and international research organizations to translate scientific innovation into clinical practice.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Egyptian Center for Research.